ethambutol has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igari, H; Imasawa, T; Ishikawa, S; Kadomura, M; Mizuno, S; Nagayoshi, M; Nishimura, M; Noguchi, N; Yamagishi, F | 1 |
| van Cauwenberge, H | 1 |
2 other study(ies) available for ethambutol and Cardiovascular Diseases
| Article | Year |
|---|---|
Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cardiovascular Diseases; Child; Drug Therapy, Combination; Ethambutol; Female; Glomerular Filtration Rate; Humans; Isoniazid; Japan; Male; Middle Aged; Pyrazinamide; Renal Insufficiency, Chronic; Retrospective Studies; Rifampin; Risk Factors; Serum Albumin; Sputum; Steroids; Streptomycin; Survival Rate; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |
[Current therapeutics in clinical medicine].
Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Cephalosporins; Endocrine System Diseases; Ethambutol; Furazolidone; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infections; Nitrofurantoin; Respiratory Tract Diseases | 1969 |